Details of Protein
General Information of Protein (ID: PRT00702) | |||||
---|---|---|---|---|---|
Name | Monocarboxylate transporter 1 (SLC16A1) | ||||
Synonyms |
Click to Show/Hide Synonyms of This Protein
MCT 1; Solute carrier family 16 member 1; SLC16A1; MCT1
|
||||
Gene Name | SLC16A1 | Gene ID | |||
UniProt ID | |||||
Family | Monocarboxylate porter (MNP) | ||||
TC Number | TC: 2.A.1.13.1 (Click to Show/Hide the Complete TC Tree) | ||||
Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Function) of This Protein | |||||
Sequence |
MPPAVGGPVGYTPPDGGWGWAVVIGAFISIGFSYAFPKSITVFFKEIEGIFHATTSEVSW
ISSIMLAVMYGGGPISSILVNKYGSRIVMIVGGCLSGCGLIAASFCNTVQQLYVCIGVIG GLGLAFNLNPALTMIGKYFYKRRPLANGLAMAGSPVFLCTLAPLNQVFFGIFGWRGSFLI LGGLLLNCCVAGALMRPIGPKPTKAGKDKSKASLEKAGKSGVKKDLHDANTDLIGRHPKQ EKRSVFQTINQFLDLTLFTHRGFLLYLSGNVIMFFGLFAPLVFLSSYGKSQHYSSEKSAF LLSILAFVDMVARPSMGLVANTKPIRPRIQYFFAASVVANGVCHMLAPLSTTYVGFCVYA GFFGFAFGWLSSVLFETLMDLVGPQRFSSAVGLVTIVECCPVLLGPPLLGRLNDMYGDYK YTYWACGVVLIISGIYLFIGMGINYRLLAKEQKANEQKKESKEEETSIDVAGKPNEVTKA AESPDQKDTDGGPKEEESPV |
||||
Structure | |||||
Function | Proton-coupled monocarboxylate transporter. Catalyzes the rapid transport across the plasma membrane of many monocarboxylates such as lactate, pyruvate, branched-chain oxo acids derived from leucine, valine and isoleucine, and the ketone bodies acetoacetate, beta-hydroxybutyrate and acetate. Depending on the tissue and on cicumstances, mediates the import or export of lactic acid and ketone bodies. Required for normal nutrient assimilation, increase of white adipose tissue and body weight gain when on a high-fat diet. Plays a role in cellular responses to a high-fat diet by modulating the cellular levels of lactate and pyruvate, small molecules that contribute to the regulation of central metabolic pathways and insulin secretion, with concomitant effects on plasma insulin levels and blood glucose homeostasis. | ||||
Regulatory Network | |||||
Full List of Metabolite(s) Regulated by This Protein | ||||||
---|---|---|---|---|---|---|
Organic acids and derivatives | ||||||
Lactic acid | Click to Show/Hide the Full List of Regulating Pair(s): 5 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Inhibition (Chloromercuribenzenesulfonic acid (pCMBS)) of SLC16A1 | |||||
Induced Change | Lactic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Breast cancer [ICD-11: 2C60] | |||||
Details | It is reported that inhibition of SLC16A1 leads to the decrease of lactic acid levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Inhibition (Diclofenac) of SLC16A1 | |||||
Induced Change | Lactic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Breast cancer [ICD-11: 2C60] | |||||
Details | It is reported that inhibition of SLC16A1 leads to the decrease of lactic acid levels compared with control group. | |||||
Regulating Pair (3) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Inhibition (Chloromercuribenzenesulfonic acid (pCMBS)) of SLC16A1 | |||||
Induced Change | Lactic acid concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Breast cancer [ICD-11: 2C60] | |||||
Details | It is reported that inhibition of SLC16A1 leads to the increase of lactic acid levels compared with control group. | |||||
Regulating Pair (4) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Inhibition (AR-C155858) of SLC16A1 | |||||
Induced Change | Lactic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Breast cancer [ICD-11: 2C60] | |||||
Details | It is reported that inhibition of SLC16A1 leads to the decrease of lactic acid levels compared with control group. | |||||
Regulating Pair (5) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Inhibition (AR-C155858) of SLC16A1 | |||||
Induced Change | Lactic acid concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Breast cancer [ICD-11: 2C60] | |||||
Details | It is reported that inhibition of SLC16A1 leads to the increase of lactic acid levels compared with control group. | |||||
Pyroglutamic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Overexpression of SLC16A1 | |||||
Induced Change | Pyroglutamic acid concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of SLC16A1 leads to the increase of pyroglutamic acid levels compared with control group. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.